Effectiveness of Paricalcitol in Reducing Parathyroid Hormone Levels in X-linked Hypophosphatemic Rickets
Diseases and Conditions Researched
Hyperparathyroidism; Hypophosphatemia, Familial
What is the purpose of this trial?
The purpose of this study is to determine the effectiveness of paricalcitol, a form of synthetic vitamin D, in lowering parathyroid hormone (PTH) levels and reducing disease symptoms in children and adults with X-linked hypophosphatemic (XLH) rickets.
Click here for detailed participation information for this trial.
|Sponsors:||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institutes of Health; Yale University|
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.